GeoVax Commences Site Expansion For Phase 2 Trial Of Next-Generation Covid-19 Vaccine

GEOVAX LABS INC +3.18%

GEOVAX LABS INC

GOVX

2.27

+3.18%

Designed to Protect Immunocompromised Patients Against Severe COVID-19

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via